Literature DB >> 17505149

In Sicilian ethnic group non-classical congenital adrenal hyperplasia is frequently associated with a very mild genotype.

M Wasniewska1, G Di Pasquale, I Rulli, G Salzano, M Caruso, S Indovina, L Di Pasquale, G Zirilli, F De Luca.   

Abstract

The spectrum of mutated alleles in non-classical congenital adrenal hyperplasia (NC-CAH) has been recently reported to be very large and haplotypes may significantly differ in the different ethnic groups. In order to confirm that population differences may exist in the genetic basis of this disease, we have analyzed the genetic presentation of NC-CAH in a Sicilian cohort of symptomatic patients and compared our findings with the ones reported in other studies of different ethnic groups. In 38 NC-CAH patients coming from two regions of Sicily and born of Sicilian parents, we found that 84.2% of the chromosomes examined bore only mild mutations and only the remaining 15.8% of the chromosomes bore at least 1 severe mutation. The overall predominant mutation was V281L, which was detected in 73.7% of alleles and in 89.5% of patients. About 58% of the patients were homozygotes for this mutation. V281L allele and homozygote frequencies were higher in the present series than in other European and Italian reports. In our NC-CAH population, which is one of the largest ever reported, the patients with two mild mutations exhibited a less severe impairment of both clinical and endocrine phenotype. On the basis of these results we can conclude that: a) in Sicilian ethnic groups NC-CAH is frequently associated with a very mild genotype; b) the most frequent genotype in our series is V281L homozygosis; c) clinical and biochemical expression of NC-CAH is more marked in the patients bearing a severe mutation; d) no correlations between genotype and phenotype were found in our patients affected by NC-CAH.

Entities:  

Mesh:

Year:  2007        PMID: 17505149     DOI: 10.1007/BF03347422

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  CYP21 analysis and phenotype/genotype relationship in the screened population of the Italian Emilia-Romagna region.

Authors:  A Balsamo; E Cacciari; L Baldazzi; L Tartaglia; A Cassio; V Mantovani; S Piazzi; A Cicognani; P Pirazzoli; B Mainetti; F Zappulla
Journal:  Clin Endocrinol (Oxf)       Date:  2000-07       Impact factor: 3.478

2.  Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency.

Authors:  P Carrera; L Bordone; T Azzani; V Brunelli; M P Garancini; G Chiumello; M Ferrari
Journal:  Hum Genet       Date:  1996-12       Impact factor: 4.132

3.  Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  C Deneux; V Tardy; A Dib; E Mornet; L Billaud; D Charron; Y Morel; F Kuttenn
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

4.  Naturally occurring mutants of human steroid 21-hydroxylase (P450c21) pinpoint residues important for enzyme activity and stability.

Authors:  A Nikoshkov; S Lajic; A Vlamis-Gardikas; L Tranebjaerg; M Holst; A Wedell; H Luthman
Journal:  J Biol Chem       Date:  1998-03-13       Impact factor: 5.157

5.  Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.

Authors:  N Krone; A Braun; A A Roscher; D Knorr; H P Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms.

Authors:  G Rumsby; C J Avey; G S Conway; J W Honour
Journal:  Clin Endocrinol (Oxf)       Date:  1998-06       Impact factor: 3.478

7.  CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations.

Authors:  Nike M M L Stikkelbroeck; Lies H Hoefsloot; Ilse J de Wijs; Barto J Otten; Ad R M M Hermus; Erik A Sistermans
Journal:  J Clin Endocrinol Metab       Date:  2003-08       Impact factor: 5.958

Review 8.  Mutations in steroid 21-hydroxylase (CYP21).

Authors:  P C White; M T Tusie-Luna; M I New; P W Speiser
Journal:  Hum Mutat       Date:  1994       Impact factor: 4.878

9.  Follow-up of 68 children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: relevance of genotype for management.

Authors:  G Pinto; V Tardy; C Trivin; C Thalassinos; S Lortat-Jacob; C Nihoul-Fékété; Y Morel; R Brauner
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

10.  High variability in CYP21A2 mutated alleles in Spanish 21-hydroxylase deficiency patients, six novel mutations and a founder effect.

Authors:  Lourdes Loidi; Celsa Quinteiro; Silvia Parajes; Jesús Barreiro; Domingo G Lestón; José M Cabezas-Agrícola; Aurelio M Sueiro; David Araujo-Vilar; Lidia Catro-Feijóo; Javier Costas; Manuel Pombo; Fernando Domínguez
Journal:  Clin Endocrinol (Oxf)       Date:  2006-03       Impact factor: 3.478

View more
  5 in total

1.  Novel mutation of CYP21A2 gene (N387K) affecting a non-conserved amino acid residue in exon 9.

Authors:  M Wasniewska; S Mirabelli; L Baldazzi; G Salzano; M F Messina; F Lombardo; M Valenzise; T Arrigo; F De Luca
Journal:  J Endocrinol Invest       Date:  2009-03-26       Impact factor: 4.256

2.  Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency.

Authors:  M Wasniewska; M Valenzise; T Aversa; S Mirabelli; F De Luca; F L De Luca; F Lombardo
Journal:  J Endocrinol Invest       Date:  2011-02       Impact factor: 4.256

3.  A large view of CYP21 locus among Sicilians and other populations: identification of a novel CYP21A2 variant in Sicily.

Authors:  M Niceta; M Bono; C Fabiano; F Pojero; F Niceta; P Sammarco; G Corsello; P Garofalo
Journal:  J Endocrinol Invest       Date:  2010-12-15       Impact factor: 4.256

4.  Non-classical 21-hydroxylase deficiency in boys with prepubertal or pubertal gynecomastia.

Authors:  Malgorzata Wasniewska; Giuseppe Raiola; Maria Concetta Galati; Giuseppina Salzano; Immacolata Rulli; Giuseppina Zirilli; Filippo De Luca
Journal:  Eur J Pediatr       Date:  2007-11-08       Impact factor: 3.183

5.  Salt-wasting congenital adrenal hyperplasia: genotypical peculiarities in a Sicilian ethnic group.

Authors:  M Wasniewska; M Caruso; S Indovina; G Crisafulli; S Mirabelli; G Salzano; T Arrigo; F De Luca
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.